期刊
JOURNAL OF INFECTIOUS DISEASES
卷 219, 期 1, 页码 26-30出版社
OXFORD UNIV PRESS INC
DOI: 10.1093/infdis/jiy466
关键词
Guillain-Barre syndrome; neutralizing antibody; flavivirus; Zika; dengue
资金
- NIH National Center for Advancing Translational Sciences [UL1TR001876, KL2TR001877]
- National Institute of Allergy and Infectious Diseases, NIH [P01AI106695]
- NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001876, KL2TR001877] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI106695] Funding Source: NIH RePORTER
The role of neutralizing antibodies in Zika-induced Guillain-Barre syndrome (GBS) has not yet been investigated. We conducted a case-control study using sera from the 2016 Zika epidemic in Colombia to determine the neutralizing antibody activity against Zika virus (ZIKV) and dengue virus serotype 2 (DENV2). We observed increased neutralizing antibody titers against DENV2 in ZIKV-infected individuals compared with uninfected controls and higher titers to both ZIKV and DENV2 in ZIKV-infected patients diagnosed with GBS compared with non-GBS ZIKV-infected controls. These data suggest that high neutralizing antibody titers to DENV and to ZIKV are associated with GBS during ZIKV infection.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据